[go: up one dir, main page]

TR200402030T4 - İkame edilen I-aminobutan-3-ol-türevleri - Google Patents

İkame edilen I-aminobutan-3-ol-türevleri

Info

Publication number
TR200402030T4
TR200402030T4 TR2004/02030T TR200402030T TR200402030T4 TR 200402030 T4 TR200402030 T4 TR 200402030T4 TR 2004/02030 T TR2004/02030 T TR 2004/02030T TR 200402030 T TR200402030 T TR 200402030T TR 200402030 T4 TR200402030 T4 TR 200402030T4
Authority
TR
Turkey
Prior art keywords
aminobutan
derivatives
substituted
drugs
compounds
Prior art date
Application number
TR2004/02030T
Other languages
English (en)
Inventor
Buschmann Helmut
Maul Corinna
Sundermann Bernd
Jagusch Utz-Peter
Haurand Michael
Chizh Boris
Original Assignee
Grnenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7658871&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200402030(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grnenthal Gmbh filed Critical Grnenthal Gmbh
Publication of TR200402030T4 publication Critical patent/TR200402030T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

Söz konusu bulus, ikame edilen I-aminobutan-3-ol-türevleriyle, bunlarin üretimine dair yöntemle, bu bilesimleri içeren ilaçlarla ve ilaçlarin üretiminde ikame edilen I-aminobutan-3-ol-türevlerinin kullanilmasiyla ilgilidir.
TR2004/02030T 2000-09-29 2001-09-28 İkame edilen I-aminobutan-3-ol-türevleri TR200402030T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10049483A DE10049483A1 (de) 2000-09-29 2000-09-29 Substituierte 1-Aminobutan-3-ol-Derivate

Publications (1)

Publication Number Publication Date
TR200402030T4 true TR200402030T4 (tr) 2004-09-21

Family

ID=7658871

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2004/02030T TR200402030T4 (tr) 2000-09-29 2001-09-28 İkame edilen I-aminobutan-3-ol-türevleri
TR2004/02230T TR200402230T4 (tr) 2000-09-29 2001-09-28 O-ikameli 6-metil-tramadol-türevleri

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2004/02230T TR200402230T4 (tr) 2000-09-29 2001-09-28 O-ikameli 6-metil-tramadol-türevleri

Country Status (29)

Country Link
US (2) US7022739B2 (tr)
EP (2) EP1322593B1 (tr)
JP (2) JP2004510755A (tr)
KR (2) KR100864796B1 (tr)
CN (2) CN100391933C (tr)
AR (1) AR034158A1 (tr)
AT (2) ATE272045T1 (tr)
AU (4) AU2001289937B2 (tr)
BR (2) BR0114381A (tr)
CA (2) CA2423860A1 (tr)
DE (3) DE10049483A1 (tr)
DK (2) DK1322592T4 (tr)
EC (2) ECSP034530A (tr)
ES (2) ES2225628T3 (tr)
HK (2) HK1052924B (tr)
HU (2) HUP0303195A3 (tr)
IL (2) IL155106A0 (tr)
MX (2) MXPA03002737A (tr)
NO (2) NO20031382L (tr)
NZ (2) NZ524976A (tr)
PE (1) PE20020413A1 (tr)
PL (2) PL361632A1 (tr)
PT (2) PT1322593E (tr)
RU (2) RU2286334C2 (tr)
SI (2) SI1322592T1 (tr)
SK (2) SK286727B6 (tr)
TR (2) TR200402030T4 (tr)
WO (2) WO2002026694A1 (tr)
ZA (2) ZA200303214B (tr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
EP1441718B1 (en) 2001-10-16 2006-07-12 Endo Pharmaceuticals Inc. Use of carbinols for the treatment of neuropathic dysfunction
PL211954B1 (pl) 2002-01-11 2012-07-31 Sankyo Co Związek, kompozycja farmaceutyczna oraz zastosowanie kompozycji farmaceutycznej
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
ES2640404T3 (es) 2002-11-22 2017-11-02 Grünenthal GmbH Combinación de analgésicos seleccionados con inhibidores de la COX II
JP2005272453A (ja) 2004-02-24 2005-10-06 Sankyo Co Ltd アミノアルコール化合物
CN101686672A (zh) * 2007-05-31 2010-03-31 塞普拉柯公司 苯基取代的环烷胺作为一元胺再摄取抑制剂
AU2009322158A1 (en) * 2008-12-05 2010-06-10 Arqule, Inc. RAF inhibitors and their uses
ES2343050B1 (es) * 2008-12-16 2011-06-14 Chemo Iberica, S.A. Procedimiento para la preparacion de desvenlafaxina y sus sales de adicion de acido farmaceuticamente aceptables.
WO2012100423A1 (en) * 2011-01-27 2012-08-02 Eli Lilly And Company Analgesic compounds, methods, and formulations
JP2019502761A (ja) * 2016-01-21 2019-01-31 ラボラトリオス レヴィ エセエレ （（ｒ）−３−［（−１−メチルピロリジン−２−イル）メチル］−５−（２−フェニルスルホニルエチル）−１ｈ−インドールを作製する方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
ZA732238B (en) * 1972-04-06 1974-01-30 American Home Prod Benzylamine analgesics
US4155935A (en) 1973-03-26 1979-05-22 American Home Products Corporation Benzylamine analgesics
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
DE19547766A1 (de) 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
DE19601744C2 (de) * 1996-01-19 1998-04-16 Gruenenthal Gmbh Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol
DE19609847A1 (de) † 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
US5919826A (en) * 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
US6245804B1 (en) * 1997-05-30 2001-06-12 Schering Aktiengesellschaft Nonsteroidal gestagens
ATE226931T1 (de) * 1997-07-15 2002-11-15 Russinsky Ltd Verfahren zur herstellung von reinem cis-tramadol
ES2212849T3 (es) * 1998-05-22 2004-08-01 Mallinckrodt Inc. Sintesis y purificacion mejoradas de hidrocloruro de (r*,r*)-2-((dimetilamino)metil)-1-(3-metoxifenil)ciclohexanol.
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
DE19915601A1 (de) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
US6562865B1 (en) * 1999-08-20 2003-05-13 Ortho-Mcneil Pharmaceutical, Inc. Composition comprising a tramadol material and an anticonvulsant drug
PE20010623A1 (es) * 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
DE10000312A1 (de) * 2000-01-05 2001-07-12 Gruenenthal Gmbh Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE10048714A1 (de) * 2000-09-30 2002-04-11 Gruenenthal Gmbh 5-Amino-1-penlen-3-ol-Derivate
US6649783B2 (en) * 2001-10-03 2003-11-18 Euro-Celtique, S.A. Synthesis of (+/-)-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols
AU2002364517A1 (en) * 2001-11-30 2003-06-17 Sepracor Inc. Tramadol analogs and uses thereof

Also Published As

Publication number Publication date
CN1478067A (zh) 2004-02-25
AU2057802A (en) 2002-04-08
IL155105A0 (en) 2003-10-31
HK1052925B (zh) 2005-04-01
ES2225605T5 (es) 2009-11-18
EP1322592A1 (de) 2003-07-02
DK1322592T3 (da) 2004-11-22
EP1322592B2 (de) 2009-06-17
DE10049483A1 (de) 2002-05-02
SI1322592T1 (en) 2005-02-28
SK3382003A3 (en) 2003-08-05
PL361632A1 (en) 2004-10-04
HK1052924B (zh) 2005-03-24
EP1322593B1 (de) 2004-07-28
RU2286334C2 (ru) 2006-10-27
ATE272046T1 (de) 2004-08-15
DK1322593T3 (da) 2004-10-11
HUP0303195A2 (hu) 2003-12-29
DK1322592T4 (da) 2009-10-12
PL361382A1 (en) 2004-10-04
RU2288219C2 (ru) 2006-11-27
DE50103036D1 (de) 2004-09-02
NZ524976A (en) 2005-01-28
KR20030059160A (ko) 2003-07-07
HUP0303361A2 (hu) 2004-03-01
TR200402230T4 (tr) 2004-10-21
US20030216393A1 (en) 2003-11-20
HUP0303195A3 (en) 2007-03-28
PT1322592E (pt) 2004-12-31
AU8993701A (en) 2002-04-15
KR100864796B1 (ko) 2008-10-23
NO20031382L (no) 2003-05-16
MXPA03002737A (es) 2004-01-26
PE20020413A1 (es) 2002-05-18
DE50103035D1 (de) 2004-09-02
ES2225605T3 (es) 2005-03-16
US7022739B2 (en) 2006-04-04
WO2002028817A1 (de) 2002-04-11
IL155106A0 (en) 2003-10-31
SI1322593T1 (en) 2004-12-31
CA2423860A1 (en) 2003-03-27
HUP0303361A3 (en) 2007-03-28
NZ525171A (en) 2006-02-24
WO2002026694A1 (de) 2002-04-04
NO20031382D0 (no) 2003-03-26
BR0114380A (pt) 2003-12-30
KR100835549B1 (ko) 2008-06-09
JP2004510755A (ja) 2004-04-08
SK3402003A3 (en) 2003-09-11
NO20031387D0 (no) 2003-03-26
CA2423903A1 (en) 2003-03-27
KR20030077531A (ko) 2003-10-01
US6828345B2 (en) 2004-12-07
MXPA03002738A (es) 2004-01-26
ECSP034532A (es) 2003-05-26
NO20031387L (no) 2003-05-21
AU2002220578B2 (en) 2006-11-30
ES2225628T3 (es) 2005-03-16
CN1466567A (zh) 2004-01-07
JP2004509939A (ja) 2004-04-02
BR0114381A (pt) 2003-12-30
ZA200303220B (en) 2004-08-19
CN100391933C (zh) 2008-06-04
ATE272045T1 (de) 2004-08-15
US20030220389A1 (en) 2003-11-27
EP1322592B1 (de) 2004-07-28
PT1322593E (pt) 2004-12-31
EP1322593A1 (de) 2003-07-02
HK1052925A1 (en) 2003-10-03
ECSP034530A (es) 2003-05-26
HK1052924A1 (en) 2003-10-03
AR034158A1 (es) 2004-02-04
SK286727B6 (sk) 2009-04-06
ZA200303214B (en) 2004-08-31
AU2001289937B2 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
NO20061736L (no) Krystallform av epotilon B
DE60107687D1 (de) Cyclpentanoindole, mischungen derartige verbindungen enthaltend und behandlungsmethoden
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
TR200400815T3 (tr) AtorvastatinÁyarı@kalsiyumunÁyeniÁkristalÁformlarıÁveÁbunlarınÁhazırlanmasıÁiçinÁişlemlerÁayrıcaÁdiğerÁformlarınÁhazırlanmasıÁiçinÁyeniÁişlemler
DE50012408D1 (de) Polyurethanlösungen mit alkoxysilanstruktureinheiten
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
DE60106954D1 (de) Resorcin-derivate
NO20010718L (no) Ny saltform av pantoprazol
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
ATE330017T1 (de) Kallikrein gen
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
NO20055741L (no) Nye kjemiske forbindelser
CY1105039T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΝΩΣΕΙΣ ΒΕΝΖΟ[b]ΑΖΕΠΙΝ-2-ΟΝΗΣ
DK1163231T3 (da) Perfluoralkylamider, deres fremstilling og deres anvendelse inden for diagnostikken
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
ATE343390T1 (de) Kalzilytische verbindungen
DE60111614D1 (de) Taxan-derivate für die behandlung von krebs
ID27733A (id) Metoksiminofenilasetamida
DE60107191D1 (de) Herstellung von 2-Hydrocarbyl-2-Adamantylacrylaten